• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

^18^F-FDG PET/MRI 用于儿童和青少年霍奇金淋巴瘤的分期和中期反应评估:以^18^F-FDG PET/CT 作为参考标准的前瞻性研究。

F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with F-FDG PET/CT as the Reference Standard.

机构信息

Department of Radiology, University College London Hospital, London, United Kingdom.

Department of Radiology, Great Ormond Street Hospital, London, United Kingdom.

出版信息

J Nucl Med. 2021 Nov;62(11):1524-1530. doi: 10.2967/jnumed.120.260059. Epub 2021 Feb 19.

DOI:10.2967/jnumed.120.260059
PMID:33608429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8612337/
Abstract

Treatment regimens for pediatric Hodgkin lymphoma (HL) depend on accurate staging and treatment response assessment, based on accurate disease distribution and metabolic activity depiction. With the aim of radiation dose reduction, we compared the diagnostic performance of F-FDG PET/MRI with a F-FDG PET/CT reference standard for staging and response assessment. Twenty-four patients (mean age, 15.4 y; range, 8-19.5 y) with histologically proven HL were prospectively and consecutively recruited in 2015 and 2016, undergoing both F-FDG PET/CT and F-FDG PET/MRI at initial staging ( = 24) and at response assessment ( = 21). The diagnostic accuracy of F-FDG PET/MRI for both nodal and extranodal disease was compared with that of F-FDG PET/CT, which was considered the reference standard. Discrepancies were retrospectively classified as perceptual or technical errors, and F-FDG PET/MRI and F-FDG PET/CT were corrected by removing perceptual error. Agreement with Ann Arbor staging and Deauville grading was also assessed. For nodal and extranodal sites combined, corrected staging F-FDG PET/MRI sensitivity was 100% (95% CI, 96.7%-100%) and specificity was 99.5% (95% CI, 98.3%-99.9%). Corrected response-assessment F-FDG PET/MRI sensitivity was 83.3% (95% CI, 36.5%-99.1%) and specificity was 100% (95% CI, 99.2%-100%). Modified Ann Arbor staging agreement between F-FDG PET/CT and F-FDG PET/MRI was perfect (κ = 1.0, = 0.000). Deauville grading agreement between F-FDG PET/MRI and F-FDG PET/CT was excellent (κ = 0.835, = 0.000). F-FDG PET/MRI is a promising alternative to F-FDG PET/CT for staging and response assessment in children with HL.

摘要

儿童霍奇金淋巴瘤(HL)的治疗方案取决于准确的分期和治疗反应评估,这需要基于准确的疾病分布和代谢活性描述。为了降低辐射剂量,我们比较了 F-FDG PET/MRI 与 F-FDG PET/CT 参考标准在分期和反应评估中的诊断性能。2015 年至 2016 年,我们前瞻性连续招募了 24 例经组织学证实的 HL 患儿(平均年龄 15.4 岁;范围 8-19.5 岁),分别在初始分期(=24)和反应评估时(=21)进行 F-FDG PET/CT 和 F-FDG PET/MRI。比较了 F-FDG PET/MRI 对结内和结外疾病的诊断准确性,将 F-FDG PET/CT 视为参考标准。通过去除感知错误,回顾性地将差异分类为感知或技术错误,并纠正 F-FDG PET/MRI 和 F-FDG PET/CT。还评估了与安阿伯分期和德沃尔夫分级的一致性。对于结内和结外部位的联合,校正后的分期 F-FDG PET/MRI 的敏感性为 100%(95%CI,96.7%-100%),特异性为 99.5%(95%CI,98.3%-99.9%)。校正后的反应评估 F-FDG PET/MRI 的敏感性为 83.3%(95%CI,36.5%-99.1%),特异性为 100%(95%CI,99.2%-100%)。F-FDG PET/CT 和 F-FDG PET/MRI 之间的改良安阿伯分期一致性为完美(κ=1.0,=0.000)。F-FDG PET/MRI 和 F-FDG PET/CT 之间的德沃尔夫分级一致性为优秀(κ=0.835,=0.000)。F-FDG PET/MRI 是一种有前途的替代 F-FDG PET/CT 的方法,可用于儿童 HL 的分期和反应评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eace/8612337/1d6f13bcf071/jnm260059absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eace/8612337/1d6f13bcf071/jnm260059absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eace/8612337/1d6f13bcf071/jnm260059absf1.jpg

相似文献

1
F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with F-FDG PET/CT as the Reference Standard.^18^F-FDG PET/MRI 用于儿童和青少年霍奇金淋巴瘤的分期和中期反应评估:以^18^F-FDG PET/CT 作为参考标准的前瞻性研究。
J Nucl Med. 2021 Nov;62(11):1524-1530. doi: 10.2967/jnumed.120.260059. Epub 2021 Feb 19.
2
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.前瞻性同日 18F-FDG PET/MRI 和 18F-FDG PET/CT 在淋巴瘤分期和疗效评估中的诊断性能。
Cancer Imaging. 2023 Jan 24;23(1):11. doi: 10.1186/s40644-023-00520-7.
3
Whole-body MRI versus an [F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.全身 MRI 与 [F]FDG-PET/CT 参考标准在儿童霍奇金淋巴瘤早期反应评估和再分期中的比较:一项前瞻性多中心研究。
Eur Radiol. 2021 Dec;31(12):8925-8936. doi: 10.1007/s00330-021-08026-1. Epub 2021 May 22.
4
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including F-FDG-PET-CT.全身 MRI 用于儿科和青少年霍奇金淋巴瘤的分期和中期反应监测:与包括 F-FDG-PET-CT 在内的多模态参考标准的比较。
Eur Radiol. 2019 Jan;29(1):202-212. doi: 10.1007/s00330-018-5445-8. Epub 2018 Jun 15.
5
Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.全身 MRI 与基于 FDG-PET/CT 的参考标准在儿科霍奇金淋巴瘤分期中的比较:一项前瞻性多中心研究。
Eur Radiol. 2021 Mar;31(3):1494-1504. doi: 10.1007/s00330-020-07182-0. Epub 2020 Sep 3.
6
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.18F-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在淋巴瘤中的应用:与18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的比较以及添加磁共振扩散加权成像的研究
Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.
7
Whole-Body Diffusion-Weighted MRI Compared to FDG PET/CT in Initial Staging and Therapy Response Assessment of Hodgkin Lymphoma in Pediatric Patients.全身扩散加权 MRI 与 FDG PET/CT 在儿科霍奇金淋巴瘤初始分期和治疗反应评估中的比较。
Can Assoc Radiol J. 2020 May;71(2):217-225. doi: 10.1177/0846537119888380. Epub 2020 Jan 22.
8
Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.全身磁共振成像用于儿童淋巴瘤的初始分期:与基于氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的参考标准进行前瞻性比较。
Eur Radiol. 2014 May;24(5):1153-65. doi: 10.1007/s00330-014-3114-0. Epub 2014 Feb 23.
9
Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study.小儿淋巴瘤的序贯PET/MRI与PET/CT对比评估:一项前瞻性研究。
AJR Am J Roentgenol. 2016 Mar;206(3):623-31. doi: 10.2214/AJR.15.15083.
10
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.PET/MRI 用于霍奇金淋巴瘤分期:前瞻性试验中 PET/CT 结果相当。
Ann Hematol. 2021 Jun;100(6):1525-1535. doi: 10.1007/s00277-021-04537-5. Epub 2021 Apr 28.

引用本文的文献

1
White paper on the current state of imaging biomarkers in paediatric oncology.儿科肿瘤学中影像生物标志物现状白皮书。
Pediatr Radiol. 2025 Sep 2. doi: 10.1007/s00247-025-06372-6.
2
Mapping the research landscape of PET/CT in lymphoma: insights from a bibliometric analysis.绘制淋巴瘤正电子发射断层扫描/计算机断层扫描(PET/CT)的研究全景:文献计量分析的见解
Front Oncol. 2025 Apr 8;15:1513296. doi: 10.3389/fonc.2025.1513296. eCollection 2025.
3
Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL.

本文引用的文献

1
Whole-Body PET/MRI Applications in Pediatric Oncology.全身 PET/MRI 在儿科肿瘤学中的应用。
AJR Am J Roentgenol. 2020 Sep;215(3):713-725. doi: 10.2214/AJR.19.22677. Epub 2020 Jul 8.
2
EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE?18F-FDG PET/CT的有效辐射剂量:诊断性CT的贡献有多大?
Radiat Prot Dosimetry. 2019 Dec 31;187(2):183-190. doi: 10.1093/rpd/ncz153.
3
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including F-FDG-PET-CT.
中枢神经系统外轴霍奇金淋巴瘤:来自 COG 和 EuroNet-PHL 的 AHOD1331、PHL-C1 和 PHL-C2 报告。
Blood Adv. 2024 Sep 24;8(18):4856-4865. doi: 10.1182/bloodadvances.2023012346.
4
Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study.弥散加权 MRI 和 18F-FDG-PET/CT 评估的儿童霍奇金淋巴瘤平均表观扩散系数 (ADC) 和最大标准摄取值 (SUVmax) 的相关性:一项可行性研究。
Radiol Oncol. 2023 Jun 21;57(2):150-157. doi: 10.2478/raon-2023-0021. eCollection 2023 Jun 1.
5
Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma.用于淋巴瘤表型分析和管理的正电子发射断层扫描分子成像
Phenomics. 2022 Feb 24;2(2):102-118. doi: 10.1007/s43657-021-00042-x. eCollection 2022 Apr.
6
Editorial: Opportunities for PET imaging for the identification, staging, and monitoring of cancers.社论:正电子发射断层显像(PET)成像在癌症识别、分期及监测中的应用机遇
Front Oncol. 2023 Jan 24;13:1135928. doi: 10.3389/fonc.2023.1135928. eCollection 2023.
7
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.前瞻性同日 18F-FDG PET/MRI 和 18F-FDG PET/CT 在淋巴瘤分期和疗效评估中的诊断性能。
Cancer Imaging. 2023 Jan 24;23(1):11. doi: 10.1186/s40644-023-00520-7.
8
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma.基线 FDG PET/MRI 联合 MTV 和 ADC 值对侵袭性非霍奇金淋巴瘤的预后价值。
BMC Cancer. 2022 Nov 1;22(1):1117. doi: 10.1186/s12885-022-10194-2.
9
Optimized low-dose positron emission tomography/computed tomography schemes in pediatric tumor patients: a randomized clinical trial.儿科肿瘤患者优化低剂量正电子发射断层扫描/计算机断层扫描方案:一项随机临床试验
Transl Pediatr. 2022 Sep;11(9):1510-1520. doi: 10.21037/tp-22-371.
10
Improving protocols for whole-body magnetic resonance imaging: oncological and inflammatory applications.改善全身磁共振成像协议:肿瘤学和炎症学应用。
Pediatr Radiol. 2023 Jun;53(7):1420-1442. doi: 10.1007/s00247-022-05478-5. Epub 2022 Aug 19.
全身 MRI 用于儿科和青少年霍奇金淋巴瘤的分期和中期反应监测:与包括 F-FDG-PET-CT 在内的多模态参考标准的比较。
Eur Radiol. 2019 Jan;29(1):202-212. doi: 10.1007/s00330-018-5445-8. Epub 2018 Jun 15.
4
Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在儿童霍奇金淋巴瘤中的当前作用
Semin Nucl Med. 2017 May;47(3):242-257. doi: 10.1053/j.semnuclmed.2017.01.001. Epub 2017 Mar 6.
5
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.用于霍奇金淋巴瘤和非霍奇金淋巴瘤治疗监测的氟代脱氧葡萄糖正电子发射断层显像(FDG PET)
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14.
6
F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?淋巴瘤患者的F-FDG PET/MRI:究竟需要多少MRI信息?
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1005-1013. doi: 10.1007/s00259-017-3635-2. Epub 2017 Feb 4.
7
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.PET/MRI与PET/CT在淋巴瘤疾病状态评估中的比较
Clin Nucl Med. 2017 Jan;42(1):e1-e7. doi: 10.1097/RLU.0000000000001344.
8
Clinical presentation and staging of Hodgkin lymphoma.霍奇金淋巴瘤的临床表现与分期
Semin Hematol. 2016 Jul;53(3):148-54. doi: 10.1053/j.seminhematol.2016.05.005. Epub 2016 May 13.
9
MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography.肺结节的磁共振成像:与计算机断层扫描相比的检出率及大小估计准确性
PLoS One. 2016 Jun 3;11(6):e0156272. doi: 10.1371/journal.pone.0156272. eCollection 2016.
10
Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.儿童淋巴瘤全身同步PET/MRI诊断性能评估
Pediatr Radiol. 2016 Aug;46(9):1258-68. doi: 10.1007/s00247-016-3601-3. Epub 2016 Mar 22.